• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强磁共振成像对小的富血供肝细胞癌的诊断准确性及肝脏影像报告和数据系统(LI-RADS)的符合率

Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).

作者信息

Bae Jae Seok, Kim Jung Hoon, Yu Mi Hye, Lee Dong Ho, Kim Hyo-Cheol, Chung Jin Wook, Han Joon Koo

机构信息

Department of Radiology, Seoul National University Hospital, Seoul, Korea.

Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea.

出版信息

PLoS One. 2017 May 30;12(5):e0178495. doi: 10.1371/journal.pone.0178495. eCollection 2017.

DOI:10.1371/journal.pone.0178495
PMID:28558068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5448778/
Abstract

BACKGROUND & AIMS: To assess diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma (HCC) detected by C-arm CT and concordance rate of Liver Imaging Reporting and Data System (LI-RADS).

METHODS

In this retrospective study, we recruited 4,544 patients suspected of having HCC underwent C-arm CT from November 2008 to May 2013. Among these patients, gadoxetic acid-enhanced MR was performed in 167 patients with HCC (n = 379; 257 > 1 cm, 122 ≤ 1 cm). HCC was confirmed by MR, CT, or follow-up images. Two radiologists graded likelihood of HCC and assessed MR features. Jackknife alternative free-response receiver operating characteristic (JAFROC) analysis was performed. All HCCs were evaluated concordance rate of LI-RADS.

RESULTS

Mean JAFROC figure of merit for large (>1-cm) HCC was 0.948, while that for small HCC was 0.787 with fair agreement (κ = 0.409). Mean sensitivity and positive predictive value (PPV) were 91% and 90% for large HCC versus 63.0% and 79% for small HCC, respectively. Seventeen of 122 small HCCs (13.9%) were not visible on MR. Among 379 HCCs, 99 met LR-5, and 259 met LR-4. Common features for small HCC included arterial enhancement (81.9%), hepatobiliary phase hypointensity (80.3%), and delayed washout (72.9%).

CONCLUSION

Diagnostic accuracy of gadoxetic acid-enhanced MR imaging for small, hypervascular HCCs (Mean figure of merit = 0.787) was still low compared with large HCC (Mean figure of merit = 0.948). LR-5 and LR-4 covered 94% (358/379) of the HCCs.

摘要

背景与目的

评估钆塞酸二钠增强磁共振成像(MR)对C臂CT检测出的小的富血管肝细胞癌(HCC)的诊断准确性以及肝脏影像报告和数据系统(LI-RADS)的符合率。

方法

在这项回顾性研究中,我们纳入了2008年11月至2013年5月期间4544例疑似患有HCC且接受了C臂CT检查的患者。在这些患者中,167例HCC患者(共379个病灶;257个病灶直径>1 cm,122个病灶直径≤1 cm)接受了钆塞酸二钠增强MR检查。HCC通过MR、CT或随访影像得以确诊。两名放射科医生对HCC的可能性进行分级并评估MR特征。采用刀切法替代自由反应接受者操作特征(JAFROC)分析。对所有HCC评估LI-RADS的符合率。

结果

大的(>1 cm)HCC的平均JAFROC品质因数为0.948,而小HCC的平均JAFROC品质因数为0.787,一致性一般(κ=0.409)。大HCC的平均敏感性和阳性预测值(PPV)分别为91%和90%,而小HCC分别为63.0%和79%。122个小HCC中有17个(13.9%)在MR上不可见。在379个HCC中,99个符合LR-5,259个符合LR-4。小HCC的常见特征包括动脉期强化(81.9%)、肝胆期低信号(80.3%)和延迟期廓清(72.9%)。

结论

与大HCC(平均品质因数=0.948)相比,钆塞酸二钠增强MR成像对小的富血管HCC的诊断准确性(平均品质因数=0.787)仍然较低。LR-5和LR-4涵盖了94%(358/379)的HCC。

相似文献

1
Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).钆塞酸二钠增强磁共振成像对小的富血供肝细胞癌的诊断准确性及肝脏影像报告和数据系统(LI-RADS)的符合率
PLoS One. 2017 May 30;12(5):e0178495. doi: 10.1371/journal.pone.0178495. eCollection 2017.
2
Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.小肝癌(≤1cm):钆塞酸增强磁共振成像的诊断性能和影像学特征。
Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996. Epub 2014 Feb 1.
3
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能:与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
4
Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.钆塞酸增强肝脏磁共振成像与多排 CT 在检测肝内不典型增生结节和早期肝细胞癌中的诊断性能比较。
Radiology. 2017 Oct;285(1):134-146. doi: 10.1148/radiol.2017162080. Epub 2017 Jun 13.
5
Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.C 臂 CT 在肝细胞癌经导管动脉化疗栓塞中的作用:与钆塞酸增强 MRI 比较的诊断性能和治疗反应预测价值。
AJR Am J Roentgenol. 2013 Sep;201(3):675-83. doi: 10.2214/AJR.12.10445.
6
Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?肝细胞癌:钆塞酸增强磁共振和弥散加权成像的 LI-RADS v2017 能否提高诊断准确性?
World J Gastroenterol. 2019 Feb 7;25(5):622-631. doi: 10.3748/wjg.v25.i5.622.
7
Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.钆塞酸二钠增强磁共振成像肝胆期上小于1厘米的低信号结节的影像学特征,这些结节在慢性肝病患者中进展为高血供肝细胞癌。
Acta Radiol. 2015 May;56(5):526-35. doi: 10.1177/0284185114534652. Epub 2014 May 16.
8
Gadoxetic acid-enhanced high temporal-resolution hepatic arterial-phase imaging with view-sharing technique: Impact on the LI-RADS category.钆塞酸增强高时间分辨率肝动脉期成像与视图共享技术:对 LI-RADS 分类的影响。
Eur J Radiol. 2017 Sep;94:167-173. doi: 10.1016/j.ejrad.2017.06.023. Epub 2017 Jul 3.
9
Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.钆塞酸增强磁共振成像在鉴别 < 或 = 2cm 直径的小肝癌和动脉期增强假性病灶中的应用:特别强调肝胆期成像。
Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.
10
Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.肝脏影像报告和数据系统(LI-RADS)v2018:计算机断层扫描与钆塞酸增强磁共振成像的比较。
Jpn J Radiol. 2019 Sep;37(9):651-659. doi: 10.1007/s11604-019-00855-x. Epub 2019 Jul 18.

引用本文的文献

1
Evidence Supporting Diagnostic Value of Liver Imaging Reporting and Data System for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.支持肝脏影像报告和数据系统对基于CT和MR成像的肝细胞癌诊断的诊断价值的证据:一项系统评价和荟萃分析。
J Biomed Phys Eng. 2024 Feb 1;14(1):5-20. doi: 10.31661/jbpe.v0i0.2211-1562. eCollection 2024 Feb.
2
Second-line Sonazoid-enhanced ultrasonography for Liver Imaging Reporting and Data System category 3 and 4 on gadoxetate-enhanced magnetic resonance imaging.钆塞酸二钠增强磁共振成像中肝脏影像报告和数据系统3类和4类病变的二线钆贝葡胺增强超声检查
Ultrasonography. 2022 Jul;41(3):519-529. doi: 10.14366/usg.21198. Epub 2022 Jan 28.
3

本文引用的文献

1
Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma.钆塞酸二钠增强肝细胞期图像对LI-RADS系统诊断肝细胞癌的附加价值
Magn Reson Med Sci. 2016;15(1):49-59. doi: 10.2463/mrms.2014-0149. Epub 2015 Jun 23.
2
C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.C形臂碘油CT在小肝细胞癌经动脉化疗栓塞术中的应用
World J Gastroenterol. 2015 Mar 14;21(10):3035-40. doi: 10.3748/wjg.v21.i10.3035.
3
Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?
Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.
肝细胞癌的磁共振成像的要点与陷阱。
World J Gastroenterol. 2020 May 7;26(17):2012-2029. doi: 10.3748/wjg.v26.i17.2012.
4
LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.LI-RADS v2014 肝细胞癌分类:钆喷酸葡胺增强 MRI 与钆塞酸二钠增强 MRI 的个体内比较。
Eur Radiol. 2019 Jan;29(1):401-410. doi: 10.1007/s00330-018-5559-z. Epub 2018 Jun 19.
钆塞酸二钠增强MRI对肝细胞癌的无创诊断:肝胆期低信号能否作为廓清的替代指标?
Eur Radiol. 2015 Oct;25(10):2859-68. doi: 10.1007/s00330-015-3686-3. Epub 2015 Mar 14.
4
Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis.肝细胞癌:多排 CT 和 MR 成像的诊断性能——系统评价和荟萃分析。
Radiology. 2015 Apr;275(1):97-109. doi: 10.1148/radiol.14140690. Epub 2015 Jan 5.
5
LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.LI-RADS(肝脏成像报告和数据系统):LI-RADS 管理工作组的总结、讨论和共识,以及未来方向。
Hepatology. 2015 Mar;61(3):1056-65. doi: 10.1002/hep.27304. Epub 2014 Dec 12.
6
Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.小肝癌(≤1cm):钆塞酸增强磁共振成像的诊断性能和影像学特征。
Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996. Epub 2014 Feb 1.
7
Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?使用钆塞酸增强 MRI 检测小肝细胞癌:3.0T 时添加弥散加权 MRI 是否有益?
J Dig Dis. 2014 Mar;15(3):137-45. doi: 10.1111/1751-2980.12119.
8
Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.C 臂 CT 在肝细胞癌经导管动脉化疗栓塞中的作用:与钆塞酸增强 MRI 比较的诊断性能和治疗反应预测价值。
AJR Am J Roentgenol. 2013 Sep;201(3):675-83. doi: 10.2214/AJR.12.10445.
9
Gastrointestinal imaging: tips and traps in the diagnosis of small HCC.胃肠道影像学:小 HCC 诊断中的技巧与陷阱。
Diagn Interv Imaging. 2013 Jul-Aug;94(7-8):697-712. doi: 10.1016/j.diii.2013.03.007. Epub 2013 Jun 7.
10
Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.在经导管动脉化疗栓塞期间,使用锥形束 CT 引导技术识别小肝癌和肿瘤供养分支。
J Vasc Interv Radiol. 2013 Apr;24(4):501-8. doi: 10.1016/j.jvir.2012.12.022. Epub 2013 Feb 26.